Primary resistance of renal adenocarcinoma to 1,2,4 triglycidylurazol (TGU, NSC 332488), a new triexpoxide cytostatic agent phase II study of the EORTC Early Clinical Trials Group

U. Bruntsch, P. Dodion, W.W. ten Bokkel Huinink, H.H. Hansen, H.M. Pinedo, M. Hansen, J. Renard, M. van Glabbeke

Research output: Contribution to journalArticleAcademicpeer-review

78 Downloads (Pure)
Original languageEnglish
Pages (from-to)697-699
JournalEuropean Journal of Cancer and Clinical Oncology
Issue number6
Publication statusPublished - 1986

Cite this